Search research articles
Contact Us
Filters
Showing results (181-190 of 240) with videos related to
Page
of 24
Sort By:
Plos One
|
November 16, 2022
Economic precarity, loneliness, and suicidal ideation during the COVID-19 pandemic
Julia Raifman, Catherine K Ettman, Lorraine T Dean, et al.
Journal of Health Politics, Policy and Law
|
March 1, 2021
Relationship between Drug Overdose Mortality and Coverage of Drug-Related Issues in US Television Political Campaign Advertising in the 2012 and 2016 Election Cycles
Alene Kennedy-Hendricks, Erika Franklin Fowler, Sachini Bandara, et al.
Preventive Medicine
|
February 27, 2018
Public support for safe consumption sites and syringe services programs to combat the opioid epidemic
Emma E McGinty, Colleen L Barry, Elizabeth M Stone, et al.
Current Addiction Reports
|
June 7, 2022
The state of the evidence on the association between state cannabis laws and opioid-related outcomes: A review
Kayla N Tormohlen, Mark C Bicket, Sarah White, et al.
Preventive Medicine
|
August 14, 2022
Racial resentment and support for decriminalization of drug possession in the United States
Saba Rouhani, Emma Elizabeth McGinty, Noelle P Weicker, et al.
JAMA Network Open
|
July 29, 2022
US Adults' Beliefs About Harassing or Threatening Public Health Officials During the COVID-19 Pandemic
Rachel J Topazian, Emma E McGinty, Hahrie Han, et al.
The American Journal of Managed Care
|
February 12, 2014
The effects of federal parity on substance use disorder treatment
Susan H Busch, Andrew J Epstein, Michael O Harhay, et al.
Drug and Alcohol Dependence
|
August 31, 2020
Elevated prevalence of antisocial behavior in adolescent children whose mothers misuse opioids
Kenneth A Feder, Mir M Ali, Laura J Sherman, et al.
Medical Care
|
February 8, 2012
Caring for grieving family members: results from a national hospice survey
Colleen L Barry, Melissa D A Carlson, Jennifer W Thompson, et al.
Psychiatric Services (Washington, D.C.)
|
January 2, 2010
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
Susan H Busch, Richard G Frank, Douglas L Leslie, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 240) with videos related to
Sort By:
Page
of 24
Plos One
|
November 16, 2022
Economic precarity, loneliness, and suicidal ideation during the COVID-19 pandemic
Julia Raifman, Catherine K Ettman, Lorraine T Dean, et al.
Journal of Health Politics, Policy and Law
|
March 1, 2021
Relationship between Drug Overdose Mortality and Coverage of Drug-Related Issues in US Television Political Campaign Advertising in the 2012 and 2016 Election Cycles
Alene Kennedy-Hendricks, Erika Franklin Fowler, Sachini Bandara, et al.
Preventive Medicine
|
February 27, 2018
Public support for safe consumption sites and syringe services programs to combat the opioid epidemic
Emma E McGinty, Colleen L Barry, Elizabeth M Stone, et al.
Current Addiction Reports
|
June 7, 2022
The state of the evidence on the association between state cannabis laws and opioid-related outcomes: A review
Kayla N Tormohlen, Mark C Bicket, Sarah White, et al.
Preventive Medicine
|
August 14, 2022
Racial resentment and support for decriminalization of drug possession in the United States
Saba Rouhani, Emma Elizabeth McGinty, Noelle P Weicker, et al.
JAMA Network Open
|
July 29, 2022
US Adults' Beliefs About Harassing or Threatening Public Health Officials During the COVID-19 Pandemic
Rachel J Topazian, Emma E McGinty, Hahrie Han, et al.
The American Journal of Managed Care
|
February 12, 2014
The effects of federal parity on substance use disorder treatment
Susan H Busch, Andrew J Epstein, Michael O Harhay, et al.
Drug and Alcohol Dependence
|
August 31, 2020
Elevated prevalence of antisocial behavior in adolescent children whose mothers misuse opioids
Kenneth A Feder, Mir M Ali, Laura J Sherman, et al.
Medical Care
|
February 8, 2012
Caring for grieving family members: results from a national hospice survey
Colleen L Barry, Melissa D A Carlson, Jennifer W Thompson, et al.
Psychiatric Services (Washington, D.C.)
|
January 2, 2010
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?
Susan H Busch, Richard G Frank, Douglas L Leslie, et al.
Page
of 24